VP-16
Term · Oncology and biomedicine · MLC-T-ONC-009322
The active ingredient in a drug used with other drugs to treat small cell lung cancer and certain types of testicular cancer. It is also being studied in the treatment of other types of cancer. VP-16 blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. It is a type of podophyllotoxin derivative and a type of topoisomerase inhibitor. Also called etoposide.
| Identifier | MLC-T-ONC-009322 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | etoposide |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009322",
"term": "VP-16",
"field": "Oncology and biomedicine",
"definition": "The active ingredient in a drug used with other drugs to treat small cell lung cancer and certain types of testicular cancer. It is also being studied in the treatment of other types of cancer. VP-16 blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. It is a type of podophyllotoxin derivative and a type of topoisomerase inhibitor. Also called etoposide.",
"expansions": [
"etoposide"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/vp-16/"
}
Record 17,355 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.